University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease : the ALL-HEART RCT and economic evaluation

dc.contributor.authorMackenzie, Isla S
dc.contributor.authorHawkey, Christopher J
dc.contributor.authorFord, Ian
dc.contributor.authorGreenlaw, Nicola
dc.contributor.authorPigazzani, Filippo
dc.contributor.authorRogers, Amy
dc.contributor.authorStruthers, Allan D
dc.contributor.authorBegg, Alan G
dc.contributor.authorWei, Li
dc.contributor.authorAvery, Anthony J
dc.contributor.authorTaggar, Jaspal S
dc.contributor.authorWalker, Andrew
dc.contributor.authorDuce, Suzanne L
dc.contributor.authorBarr, Rebecca J
dc.contributor.authorDumbleton, Jennifer S
dc.contributor.authorRooke, Evelien D
dc.contributor.authorTownend, Jonathan N
dc.contributor.authorRitchie, Lewis D
dc.contributor.authorMacDonald, Thomas M
dc.contributor.authorALL-HEART Study Group
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2024-04-16T09:50:00Z
dc.date.available2024-04-16T09:50:00Z
dc.date.issued2024-03-01
dc.descriptionFunding: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 11/36/41) and is published in full in Health Technology Assessment; Vol. 28, No. 18. See the NIHR Funding and Awards website for further award information.en
dc.description.statusPeer revieweden
dc.format.extent86
dc.format.extent2297157
dc.identifier288861211
dc.identifiera3f18e53-f758-4ae2-90f0-74074b08ff0a
dc.identifier38551218
dc.identifier85189277239
dc.identifier.citationMackenzie, I S, Hawkey, C J, Ford, I, Greenlaw, N, Pigazzani, F, Rogers, A, Struthers, A D, Begg, A G, Wei, L, Avery, A J, Taggar, J S, Walker, A, Duce, S L, Barr, R J, Dumbleton, J S, Rooke, E D, Townend, J N, Ritchie, L D, MacDonald, T M & ALL-HEART Study Group 2024, 'Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease : the ALL-HEART RCT and economic evaluation', Health technology assessment (Winchester, England), vol. 28, no. 18. https://doi.org/10.3310/ATTM4092en
dc.identifier.doi10.3310/ATTM4092
dc.identifier.iss18en
dc.identifier.issn1366-5278
dc.identifier.urihttps://hdl.handle.net/2164/23247
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85189277239&partnerID=8YFLogxKen
dc.identifier.vol28en
dc.language.isoeng
dc.relation.ispartofHealth technology assessment (Winchester, England)en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectAgeden
dc.subjectFemaleen
dc.subjectAllopurinol/therapeutic useen
dc.subjectCost-Benefit Analysisen
dc.subjectAcute Coronary Syndromeen
dc.subjectQuality of Lifeen
dc.subjectProspective Studiesen
dc.subjectUric Aciden
dc.subjectMyocardial Ischemia/drug therapyen
dc.subjectGout/drug therapyen
dc.subjectStroke/drug therapyen
dc.subjectMyocardial Infarction/drug therapyen
dc.subjectR Medicineen
dc.subjectRA0421 Public health. Hygiene. Preventive Medicineen
dc.subjectNational Institute for Health Research (NIHR)en
dc.subject11/36/41en
dc.subject.lccRen
dc.subject.lccRA0421en
dc.titleAllopurinol and cardiovascular outcomes in patients with ischaemic heart disease : the ALL-HEART RCT and economic evaluationen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Mackenzie_etal_HTA_Allopurinol_And_Cardivascular_VoR.pdf
Size:
2.19 MB
Format:
Adobe Portable Document Format

Collections